Four U.S. senators led by Bernie Sanders, I-Vt., have sent letters to the four largest inhaler manufacturers – AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK) and Teva Pharmaceuticals – informing them of an investigation into inhaler prices, which the senators called “outrageous.”
Senators call inhaler prices ‘outrageous,’ pressure drugmakers
